rs1554843116
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PM4PP3
The NM_201596.3(CACNB2):c.1851_1859dupCCACAACGA(p.Asp617_Asn619dup) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E620E) has been classified as Likely benign.
Frequency
Consequence
NM_201596.3 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- Brugada syndrome 4Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- short QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNB2 | NM_201596.3 | c.1851_1859dupCCACAACGA | p.Asp617_Asn619dup | disruptive_inframe_insertion | Exon 14 of 14 | ENST00000324631.13 | NP_963890.2 | |
| CACNB2 | NM_201590.3 | c.1689_1697dupCCACAACGA | p.Asp563_Asn565dup | disruptive_inframe_insertion | Exon 13 of 13 | ENST00000377329.10 | NP_963884.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNB2 | ENST00000324631.13 | c.1851_1859dupCCACAACGA | p.Asp617_Asn619dup | disruptive_inframe_insertion | Exon 14 of 14 | 1 | NM_201596.3 | ENSP00000320025.8 | ||
| CACNB2 | ENST00000377329.10 | c.1689_1697dupCCACAACGA | p.Asp563_Asn565dup | disruptive_inframe_insertion | Exon 13 of 13 | 1 | NM_201590.3 | ENSP00000366546.4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Brugada syndrome 4 Uncertain:1
Experimental studies investigating the functional effect of this duplication have not been published in the literature. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a CACNB2-related disease. This sequence change inserts 9 nucleotides in exon 13 of the CACNB2 mRNA (c.1689_1697dupCCACAACGA). This leads to the insertion of 3 amino acid residue(s) in the CACNB2 protein (p.Asp563_Asn565dup) but otherwise preserves the integrity of the reading frame. In summary, this is a novel sequence change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at